Oseltamivir May or May Not Reduce Hospitalizations

JAMA Intern Med. 2024 Jan 1;184(1):116-117. doi: 10.1001/jamainternmed.2023.4720.

Authors

James W Antoon¹, Carlos G Grijalva², Keipp Talbot³

Affiliations

¹ Division of Hospital Medicine, Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee.
² Division of Pharmacoepidemiology, Departments of Health Policy and Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee.
³ Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.

PMID: 37983034
PMCID: PMC10843694 (available on 2025-01-01)
DOI: 10.1001/jamainternmed.2023.4720

No abstract available

MeSH terms

Antiviral Agents / therapeutic use
Hospitalization
Humans
Influenza, Human* / drug therapy
Influenza, Human* / prevention & control
Oseltamivir* / therapeutic use

Substances

Oseltamivir
Antiviral Agents

Grants and funding

K23 AI168496/AI/NIAID NIH HHS/United States